Related Experiment Video
Updated: Aug 9, 2026

Measurement of Heme Synthesis Levels in Mammalian Cells
Published on: July 9, 2015
Serum alpha-hydroxybutyrate dehydrogenase levels in children with sickle cell disease
Insights
Serum alpha-hydroxybutyrate dehydrogenase (alpha-HBDH) levels help distinguish sickle cell disease (SCD) crises from infections. Elevated alpha-HBDH indicates a crisis, while normal levels suggest infection in SCD patients.
Area of Science:
- Biochemistry
- Hematology
- Pediatrics
Background:
- Sickle cell disease (SCD) is a genetic blood disorder with significant health complications.
- Differentiating between vaso-occlusive crises and infections is crucial for effective SCD management.
- Serum biomarkers can aid in diagnosing acute complications in SCD.
Purpose of the Study:
- To investigate serum alpha-hydroxybutyrate dehydrogenase (alpha-HBDH) levels in children with sickle cell disease (SCD).
- To determine if alpha-HBDH levels can differentiate between steady state, vaso-occlusive crisis, and infection in SCD patients.
Main Methods:
- Serum alpha-HBDH levels were measured in 28 children with homozygous SCD during steady state, crisis, and postcrisis.
- Alpha-HBDH levels were also assessed in 20 patients with infection.
- Levels were compared to control values and between different clinical states.
Main Results:
- Children with SCD in the steady state showed significantly elevated alpha-HBDH levels compared to controls.
- A further significant increase in alpha-HBDH levels was observed during vaso-occlusive crises.
- Patients with infection did not exhibit a significant increase in serum alpha-HBDH levels.
Conclusions:
- Serum alpha-HBDH levels are significantly elevated in SCD patients during steady state and crisis.
- Elevated alpha-HBDH levels can effectively differentiate vaso-occlusive crises from infections in SCD.
- This biomarker aids in accurate diagnosis and management of SCD complications.
Abstract:
Serum alpha-hydroxybutyrate dehydrogenase (alpha-HBDH) levels were determined in 28 children with homozygous sickle cell disease (SCD) during the steady state, crisis, and postcrisis periods. Serum alpha-HBDH levels were also studied in 20 patients with infection. In patients during the steady state, serum alpha-HBDH levels were significantly above control values. During the vaso-occlusive crisis there was a significant further increase in the alpha-HBDH levels. In patients with infection, however, there was no significant increase in serum alpha-HBDH levels. These findings clearly indicate that the level of serum alpha-HBDH in patients with SCD permits differentiation between vaso-occlusive crises, infection, and spurious symptoms.
More Related Videos
Related Concept Videos
Hyperosmolar Hyperglycemic State
Jaundice

